281 related articles for article (PubMed ID: 19098375)
21. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes.
Sakthong P; Chabunthom R; Charoenvisuthiwongs R
Ann Pharmacother; 2009 May; 43(5):950-7. PubMed ID: 19366872
[TBL] [Abstract][Full Text] [Related]
22. The Danish version of the Medication Adherence Report Scale: preliminary validation in cancer pain patients.
Jacobsen R; Møldrup C; Christrup L; Sjøgren P; Hansen OB
Pain Pract; 2009; 9(1):1-7. PubMed ID: 19019056
[TBL] [Abstract][Full Text] [Related]
23. Patients differ in their ability to self-monitor adherence to a low-sodium diet versus medication.
Chung ML; Lennie TA; de Jong M; Wu JR; Riegel B; Moser DK
J Card Fail; 2008 Mar; 14(2):114-20. PubMed ID: 18325457
[TBL] [Abstract][Full Text] [Related]
24. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany.
Mahler C; Hermann K; Horne R; Ludt S; Haefeli WE; Szecsenyi J; Jank S
J Eval Clin Pract; 2010 Jun; 16(3):574-9. PubMed ID: 20210821
[TBL] [Abstract][Full Text] [Related]
25. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease.
Bane C; Hughes CM; McElnay JC
Patient Educ Couns; 2006 Feb; 60(2):187-93. PubMed ID: 16253468
[TBL] [Abstract][Full Text] [Related]
26. Adherence analysis using visual analog scale versus claims-based estimation.
Nau DP; Steinke DT; Williams LK; Austin R; Lafata JE; Divine G; Pladevall M
Ann Pharmacother; 2007 Nov; 41(11):1792-7. PubMed ID: 17925497
[TBL] [Abstract][Full Text] [Related]
27. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
[TBL] [Abstract][Full Text] [Related]
28. Adherence to asthma therapy in elderly patients.
Bozek A; Jarzab J
J Asthma; 2010 Mar; 47(2):162-5. PubMed ID: 20170323
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of a provincial prescription database for assessing medication adherence in heart failure patients.
Dahri K; Shalansky SJ; Jang L; Jung L; Ignaszewski AP; Clark C
Ann Pharmacother; 2008 Mar; 42(3):361-7. PubMed ID: 18303147
[TBL] [Abstract][Full Text] [Related]
30. Medication adherence self-report instruments: implications for practice and research.
Rolley JX; Davidson PM; Dennison CR; Ong A; Everett B; Salamonson Y
J Cardiovasc Nurs; 2008; 23(6):497-505. PubMed ID: 18953213
[TBL] [Abstract][Full Text] [Related]
31. Adherence to treatment in children and adolescent patients with cystic fibrosis.
Zindani GN; Streetman DD; Streetman DS; Nasr SZ
J Adolesc Health; 2006 Jan; 38(1):13-7. PubMed ID: 16387243
[TBL] [Abstract][Full Text] [Related]
32. Adapting electronic adherence monitors to standard packages of topical medications.
Tusa MG; Ladd M; Kaur M; Balkrishnan R; Feldman SR
J Am Acad Dermatol; 2006 Nov; 55(5):886-7. PubMed ID: 17052499
[TBL] [Abstract][Full Text] [Related]
33. Medication adherence in older renal transplant recipients.
Russell CL; Cetingok M; Hamburger KQ; Owens S; Thompson D; Hathaway D; Winsett RP; Conn VS; Madsen R; Sitler L; Wakefield MR
Clin Nurs Res; 2010 May; 19(2):95-112. PubMed ID: 20185804
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy.
Ayoade A; Oladipo I
Blood Press; 2012 Jun; 21(3):161-6. PubMed ID: 22512239
[TBL] [Abstract][Full Text] [Related]
35. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
Bruce JM; Hancock LM; Lynch SG
Mult Scler; 2010 Jan; 16(1):112-20. PubMed ID: 19995835
[TBL] [Abstract][Full Text] [Related]
36. Adherence to antiparkinson medication in a multicenter European study.
Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
[TBL] [Abstract][Full Text] [Related]
37. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients.
Buscher A; Hartman C; Kallen MA; Giordano TP
HIV Clin Trials; 2011; 12(5):244-54. PubMed ID: 22180522
[TBL] [Abstract][Full Text] [Related]
38. Comparison of methods to assess medication adherence and classify nonadherence.
Hansen RA; Kim MM; Song L; Tu W; Wu J; Murray MD
Ann Pharmacother; 2009 Mar; 43(3):413-22. PubMed ID: 19261962
[TBL] [Abstract][Full Text] [Related]
39. Derivation and validation of the ASK-12 adherence barrier survey.
Matza LS; Park J; Coyne KS; Skinner EP; Malley KG; Wolever RQ
Ann Pharmacother; 2009 Oct; 43(10):1621-30. PubMed ID: 19776298
[TBL] [Abstract][Full Text] [Related]
40. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
